| Nucleosidic DNA demethylating epigenetic drugs–A comprehensive review from discovery to clinic K Agrawal, V Das, P Vyas, M Hajdúch Pharmacology & therapeutics, 2018 | 127 | 2018 |
| Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer’s disease N Annadurai, K Agrawal, P Džubák, M Hajdúch, V Das Cellular and Molecular Life Sciences 74 (22), 4159-4169, 2017 | 44 | 2017 |
| Cell‐based DNA demethylation detection system for screening of epigenetic drugs in 2D, 3D, and xenograft models K Agrawal, V Das, M Otmar, M Krečmerová, P Džubák, M Hajdúch Cytometry Part A 91 (2), 133-143, 2017 | 10 | 2017 |
| Differential regulation of methylation‐regulating enzymes by senescent stromal cells drives colorectal cancer cell response to DNA‐demethylating Epi‐drugs K Agrawal, V Das, N Táborská, J Gurský, P Džubák, M Hajdúch Stem Cells International 2018 (1), 6013728, 2018 | 8 | 2018 |
| Chromatin reader machinery as target for overcoming resistance to DNA-demethylating epi-drug decitabine K Agrawal, P Vojta, R Slavkosky, I Frydrych, P Dzubak, M Hajduch Cancer Research 79 (13_Supplement), 5182-5182, 2019 | 3 | 2019 |
| Biodegradable system for drug delivery of hydrolytically labile azanucleoside drugs M Hruby, K Agrawal, O Policianova, J Brus, J Skopal, P Svec, M Otmar, ... Biomedical papers 160 (2), 222-230, 2016 | 3 | 2016 |
| Laboratory Techniques in Cellular and Molecular Medicine K Agrawal, J Bouchal, DAS VISWANATH Palacký University Olomouc, 2021 | 2 | 2021 |
| 5-azacytidine nucleosides and their derivatives: Molecular hallmarks of drug resistance K Agrawal, P Dzubak, I Frydrych, D Holub, P Vojta, M Krecmerova, ... Cancer Research 74 (19 Supplement), 400-400, 2014 | 1 | 2014 |
| Reporter based DNA demethylation detection system K Agrawal LABORATORY TECHNIQUES IN CELLULAR AND MOLECULAR MEDICINE, 153, 2021 | | 2021 |
| Abstract B085: Low-sensitivity and drug-resistance to DNA-demethylating epi-drug decitabine in solid tumors: A challenge yet to overcome K Agrawal, P Vojta, R Slavkosky, I Frydrych, P Dzubak, M Hajduch Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_2), B085-B085, 2020 | | 2020 |
| Faculty of Medicine and Dentistry K Agrawal Palacký University Olomouc, 2017 | | 2017 |
| Stromal cell-induced alterations in the response of colorectal cancer cell to demethylating agents V Das, S Skolekova, K Agrawal, J Gursky, L Kučerová, M Hajdúch Cancer Research 76 (14 Supplement), 4101-4101, 2016 | | 2016 |
| Molecular hallmarks of drug resistance to DNA methylation inhibitors and alternative therapeutic regimen for overcoming resistance K Agrawal, P Vojta, D Holub, R Slavkovsky, I Frydrych, P Dzubak, ... Cancer Research 76 (14 Supplement), 4453-4453, 2016 | | 2016 |
| Abstract B72: Cell-based DNA demethylation detection system for screening of epigenetic drugs in 2D, 3D and xenograft models K Agrawal, V Das, M Otmar, M Krecmerova, P Dzubak, M Hajduch Molecular Cancer Therapeutics 14 (12 Supplement 2), B72-B72, 2015 | | 2015 |
| 5-azacytidine nucleosides and their derivatives: Molecular hallmarks of drug resistance & alternative therapeutic regimen K Agrawal, P Vojta, D Holub, I Frydrych, P Džubák, M Otmar, ... Cancer Research 75 (15 Supplement), 2944-2944, 2015 | | 2015 |
| Method of predicting the tumor response to DNA methylation inhibitors and alternative therapeutic regimens for overcoming resistance K Agrawal, P Dzubak, I Hajduch, Marian, Frydrych EP Patent EP 2 924 125 A1, 2015 | | 2015 |
